TiernaLM,MepheeSJ,PapadakisMA, 2002.Diabetes mellitus and hypoglycemia. Current medical diagnosis and treatment,41st ed. New York: McGraw Hill 1203 -44
WildS,RoglicG,GreenA,SicreeR,KingH, 2004.Diabetes care, 27 1047 -53
Russell-JonesD,VaagA,SchmitzO,SethiBK,LalicN,AnticS, 2009.Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+ SU): a randomised controlled trial,Diabetologia 52 2046 -55
MorrisDH,KhuntiK,AchanaF,SrinivasanB,GrayLJ,DaviesMJ, 2013.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis Diabetologia,Progression rates from HbA1c 6 56 1489 -93
WhiteWB,PratleyR,FleckP,MunsakaM,HisadaM,WilsonC, 2013.Cardiovascular safety of the dipeptidyl peptidase-4 inhibitor alogliptin in type 2 diabetes mellitus,Diabetes, Obesity and Metabolism 15 668 -73
Kaneto H. Pancreatic, 2016.-cell failure in type 2 diabetes mellitus,Expert Review of Endocrinology & Metabolism 11 1 -2
Ismail-Beigi F, 2012.Glycemic management of type 2 diabetes mellitus,New England Journal of Medicine 366 1319 -27
DeFronzoRA, 2000.Pharmacologic therapy for type 2 diabetes mellitus,Annals of internal medicine 133 73 -
Kolterman , O.G, 2003.Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with T2DM,J. Clin. Endocrinol. Metab 132 3082 -3089
Nielsen , L.L.,Young , A.A.,Parkes , D.G., 2004.Pharmacology of exenatide (synthetic exendin-4): A potential therapeutic for improves glycemic control of T2DM, 117 77 -88
Pabreja , K., 2014."Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation,British journal of pharmacology 171 1114 -1128
2006.Chansouria; Hypolipidemic activity of aqueous extract of Withania coagulans Dunal in albino rats,Phytotherapy Research 20 614 -617
JaiswalD,RaiPK,WatalG, 2009.Antidiabetic effect of Withania coagulans in experimental rats,Indian Journal of Clinical Biochemistry 24 88 -93
ShuklaK, 2014.Hypolipidemic and antioxidant activity of aqueous extract of fruit of Withania coagulans (Stocks) Dunal in cholesterol-fed hyperlipidemic rabbit model,Indian Journal of Experimental biology 56 870 -875
BhartiSK, 2012.Antidiabetic effect of aqueous extract of Withania coagulans flower inPoloxamer-407 induced type 2 diabetic rats,Journal of Medicinal Plants Research 6 5706 -13
ShuklaK,DikshitP,ShuklaR,GambhirJK, 2012.The aqueous extract of Withania coagulans fruit partially reverses nicotinamide/streptozotocin-induced diabetes mellitus in rats,Journal of medicinal food 15 718 -25
Datta, 2013.A etal. Antidiabetic and antihyperlipidemic activity of hydroalcoholic extracts of Withania coagulans Dunal dried fruit in experimental rat models,Journal of Ayurveda and integrative medicine 4 99 -04
AlamA,SiddiquiMY,HakimMH., 2009.Clinical efficacy of Withania coagulans Dunal and Trigonella foenum-graecum Linn. in Type 2 Diabetes mellitus,Indian journal of traditional Knowledge 8 405 -409
DaviesMJ, 2015.Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial,Jama 314 687 -99
UpadhyayBN,GuptaV., 2011.A clinical study on the effect of Rishyagandha (Withania coagulans) in the management of Prameha (Type II Diabetes Mellitus),AYU (An international quarterly Journal of research in Ayurveda) 32 507 -12